Latham & Watkins represented the underwriters in the offering. Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to...
Eliem Therapeutics’ $80 Million Initial Public Offering
Hippo’s Merger with Reinvent Technology Partners Z
Latham & Watkins LLP acted as Hippo’s legal counsel, while Sullivan & Cromwell LLP served as Reinvent’s legal counsel for the transaction. Davis Polk advised the...